Molecular cloning, chromosomal mapping, and expression of the mouse p107 gene

被引:7
作者
Huppi, K [1 ]
Siwarski, D [1 ]
Mock, BA [1 ]
Dosik, J [1 ]
Hamel, PA [1 ]
机构
[1] UNIV TORONTO,DEPT MOLEC & CELLULAR PATHOL,TORONTO,ON M5S 1A8,CANADA
关键词
D O I
10.1007/s003359900102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Progression through the G1 phase of the cell cycle is regulated, in part, by the pRB-family proteins, pRB and p107. The basis for this regulation is due to a network of interactions between the pRB-family proteins, pRB, p107, and p130; the E2F-family of transcription factors; and cyclins D, E, and A. One of the pRB-family proteins, p107, has also been found to bind to the transactivation domain of the c-Myc proto-oncogene. This region in c-Myc is frequently mutated in tumors such as Burkitt's lymphoma, HIV-associated lymphoma, and multiple myeloma. The binding of p107 and regulation of c-Myc may conceivably be disrupted not only by mutations in c-Myc, but possibly by mutations in p107. In order to determine if mutations in p107 are indeed present in mouse B-cell tumors which exhibit a lower frequency of c-Myc mutation, we have cloned the mouse p107 cDNA and compared this sequence with its human counterpart. We find that the extreme N-terminal and C-terminal regions are the most conserved between human and mouse p107 sequences. Chromosomal positioning of the locus for p107 (designated Rbl1) as well as E2f1 to the distal end of mouse Chromosome (Chr) 2 also suggests a close but unlinked genetic relationship between these cell cycle regulatory transcription factors.
引用
收藏
页码:353 / 355
页数:3
相关论文
共 26 条
  • [1] INTERACTION OF C-MYC WITH THE PRB-RELATED PROTEIN P107 RESULTS IN INHIBITION OF C-MYC-MEDIATED TRANSACTIVATION
    BEIJERSBERGEN, RL
    HIJMANS, EM
    ZHU, L
    BERNARDS, R
    [J]. EMBO JOURNAL, 1994, 13 (17) : 4080 - 4086
  • [2] E2F-4, A NEW MEMBER OF THE E2F GENE FAMILY, HAS ONCOGENIC ACTIVITY AND ASSOCIATES WITH P107 IN-VIVO
    BEIJERSBERGEN, RL
    KERKHOVEN, RM
    ZHU, LA
    CARLEE, L
    VOORHOEVE, PM
    BERNARDS, R
    [J]. GENES & DEVELOPMENT, 1994, 8 (22) : 2680 - 2690
  • [3] BHATIA K, 1994, BLOOD, V84, P883
  • [4] POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS
    BHATIA, K
    HUPPI, K
    SPANGLER, G
    SIWARSKI, D
    IYER, R
    MAGRATH, I
    [J]. NATURE GENETICS, 1993, 5 (01) : 56 - 61
  • [5] CLARK HM, 1994, CANCER RES, V54, P3383
  • [6] INTERACTION OF P107 WITH CYCLIN-A INDEPENDENT OF COMPLEX-FORMATION WITH VIRAL ONCOPROTEINS
    EWEN, ME
    FAHA, B
    HARLOW, E
    LIVINGSTON, DM
    [J]. SCIENCE, 1992, 255 (5040) : 85 - 87
  • [7] MOLECULAR-CLONING, CHROMOSOMAL MAPPING, AND EXPRESSION OF THE CDNA FOR P107, A RETINOBLASTOMA GENE PRODUCT-RELATED PROTEIN
    EWEN, ME
    XING, YG
    LAWRENCE, JB
    LIVINGSTON, DM
    [J]. CELL, 1991, 66 (06) : 1155 - 1164
  • [8] INTERACTION BETWEEN HUMAN CYCLIN-A AND ADENOVIRUS E1A-ASSOCIATED P107 PROTEIN
    FAHA, B
    EWEN, ME
    TSAI, LH
    LIVINGSTON, DM
    HARLOW, E
    [J]. SCIENCE, 1992, 255 (5040) : 87 - 90
  • [9] E2F-4, A NEW MEMBER OF THE E2F TRANSCRIPTION FACTOR FAMILY, INTERACTS WITH P107
    GINSBERG, D
    VAIRO, G
    CHITTENDEN, T
    XIAO, ZX
    XU, GF
    WYDNER, KL
    DECAPRIO, JA
    LAWRENCE, JB
    LIVINGSTON, DM
    [J]. GENES & DEVELOPMENT, 1994, 8 (22) : 2665 - 2679
  • [10] BINDING AND SUPPRESSION OF THE MYC TRANSCRIPTIONAL ACTIVATION DOMAIN BY P107
    GU, W
    BHATIA, K
    MAGRATH, IT
    DANG, CV
    DALLAFAVERA, R
    [J]. SCIENCE, 1994, 264 (5156) : 251 - 254